Irogreat-XT Tablet contains Ferrous Ascorbate 100 mg and Folic Acid 1.5 mg, formulated to effectively treat and prevent iron deficiency anemia and folate deficiency. Ferrous Ascorbate, a highly bioavailable form of iron combined with ascorbic acid (vitamin C), enhances iron absorption in the gastrointestinal tract, thereby replenishing iron stores and improving hemoglobin synthesis. Folic Acid, a vital B-vitamin, plays a crucial role in DNA synthesis, red blood cell formation, and cellular growth, making it essential for correcting folate deficiency anemia and supporting overall hematopoiesis. Irogreat-XT is indicated for patients with iron deficiency anemia due to nutritional deficiencies, pregnancy, lactation, chronic blood loss, or malabsorption syndromes. It is also beneficial in preventing neural tube defects during pregnancy by ensuring adequate folate levels. The combination therapy addresses both iron and folate deficiencies simultaneously, promoting effective and rapid correction of anemia. Administration should be as prescribed by a healthcare professional, considering patient-specific factors such as severity of anemia and tolerance. Common side effects may include gastrointestinal discomfort, nausea, constipation, or darkened stools, which are generally mild and transient. Regular monitoring of hemoglobin levels and iron status is recommended during therapy to assess efficacy and avoid iron overload.